
The FDA has approved Crysvita (burosumabtwza) injection to treat patients over two years old with tumour-induced osteomalacia (TIO). This is …

The FDA announced on Wednesday that it approved Bristol-Myers Squibb’s Opdivo in combination with Yervoy to treat patients with hepatocellular …

The Fitch ratings agency has published pessimistic projections for pharma, saying that it should not expect as many US drug …
AstraZeneca and Bristol-Myers Squibb must supply more data on their diabetes treatment dapagliflozin, the FDA says.Currently being developed as monotherapy, …
The European Medicines Agency approves fewer new oncology drugs than its US counterpart and takes nearly twice as long to …